CRSP Stock Analysis: Buy, Sell, or Hold?
CRSP - CRISPR Therapeutics AG
$59.50
1.38 (2.37%)
▲
5d:
+11.11%
30d:
+25.18%
90d:
+19.24%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 21, 2026 at $61.06 · last confirmed Aug 21, 2026
Strength: 6.0/10
Get Alerted When CRSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CRSP shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CRSP shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CRSP is currently trading at $59.50, which is considered extended relative to its 30-day fair value range of $47.55 to $54.96.
Technical Outlook: Technically, CRSP is in a strong uptrend. Immediate support is located at $51.80, while resistance sits at $62.53.
Market Sentiment: CRSP scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $87.56 (+47.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRSP is in a strong uptrend. Immediate support is located at $51.80, while resistance sits at $62.53.
Market Sentiment: CRSP scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $87.56 (+47.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$47.55 -
$54.96
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
21.1%
Protect Your Profits
Holding CRSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+8.3% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 47.2% below Wall St target ($87.56)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$47.55 -
$54.96
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$51.80
Resistance Level
$62.54
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.01
Wall Street Target
$87.56
(+47.2%)
Revenue Growth (YoY)
1041.4%
Share & Embed Analysis
Last updated: August 24, 2026 12:06 AM ET
Data refreshes hourly during market hours. Next update: 1:06 AM
Data refreshes hourly during market hours. Next update: 1:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
James R Kasinger
SELL
3182 shares
2026-03-23
Samarth Kulkarni
SELL
10020 shares
2026-03-23
James R Kasinger
SELL
3450 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 40 SELL |
Advanced CRSP Option Strategies
Professional options setups generated by AI based on today's CRSP price and gamma walls.
